166 related articles for article (PubMed ID: 3027640)
1. Studies on the standardization of mistletoe preparations.
Wagner H; Jordan E; Feil B
Oncology; 1986; 43 Suppl 1():16-22. PubMed ID: 3027640
[TBL] [Abstract][Full Text] [Related]
2. [Detection and quantitative determination of lectins and viscotoxins in mistletoe preparations].
Jordan E; Wagner H
Arzneimittelforschung; 1986 Mar; 36(3):428-33. PubMed ID: 3707660
[TBL] [Abstract][Full Text] [Related]
3. Characterization of cytotoxic proteins from mistletoe (Viscum album L.).
Jung ML; Baudino S; Ribéreau-Gayon G; Beck JP
Cancer Lett; 1990 May; 51(2):103-8. PubMed ID: 2344587
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a toxic lectin in Iscador, a mistletoe preparation with alleged cancerostatic properties.
Holtskog R; Sandvig K; Olsnes S
Oncology; 1988; 45(3):172-9. PubMed ID: 3368193
[TBL] [Abstract][Full Text] [Related]
5. Isolation and characterization of biologically active lectin from Korean mistletoe, Viscum album var. Coloratum.
Lee HS; Kim YS; Kim SB; Choi BE; Woo BH; Lee KC
Cell Mol Life Sci; 1999 Apr; 55(4):679-82. PubMed ID: 10357236
[TBL] [Abstract][Full Text] [Related]
6. Mistletoe lectins and their A and B chains.
Franz H
Oncology; 1986; 43 Suppl 1():23-34. PubMed ID: 3543782
[TBL] [Abstract][Full Text] [Related]
7. Detection of isolated mistletoe lectin chains in plant extracts.
Tonevitsky AG; Marx U; Agapov I; Moisenovich M
Arzneimittelforschung; 2002; 52(1):67-71. PubMed ID: 11838276
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of fermented and unfermented mistletoe preparations on cultured tumor cells.
Ribéreau-Gayon G; Jung ML; Di Scala D; Beck JP
Oncology; 1986; 43 Suppl 1():35-41. PubMed ID: 3808575
[TBL] [Abstract][Full Text] [Related]
9. [Ingredients of mistletoe (Viscum album L.) as potential drugs].
Franz H
Pharmazie; 1985 Feb; 40(2):97-104. PubMed ID: 3889937
[No Abstract] [Full Text] [Related]
10. Induction of apoptosis in human lymphocytes treated with Viscum album L. is mediated by the mistletoe lectins.
Büssing A; Suzart K; Bergmann J; Pfüller U; Schietzel M; Schweizer K
Cancer Lett; 1996 Jan; 99(1):59-72. PubMed ID: 8564930
[TBL] [Abstract][Full Text] [Related]
11. Induction of anti-mistletoe lectin antibodies in relation to different mistletoe-extracts.
Stein GM; Stettin A; Schultze J; Berg PA
Anticancer Drugs; 1997 Apr; 8 Suppl 1():S57-9. PubMed ID: 9179370
[TBL] [Abstract][Full Text] [Related]
12. Calibration of colorimetric protein assays for quantitation of plant AB toxins.
Jiménez M; André S; Gabius HJ; Solís D
Anal Biochem; 2000 Sep; 284(2):418-20. PubMed ID: 10964431
[No Abstract] [Full Text] [Related]
13. Study of heterogeneity of lectins in mistletoe preparations by monoclonal antibodies to their A-subunits.
Tonevitsky AG; Agapov I; Temiakov D; Moisenovich M; Maluchenko N; Solopova O; Würzner G; Pfueller U
Arzneimittelforschung; 1999 Nov; 49(11):970-5. PubMed ID: 10604051
[TBL] [Abstract][Full Text] [Related]
14. In vivo-induction of antibodies to mistletoe lectin-1 and viscotoxin by exposure to aqueous mistletoe extracts: a randomised double-blinded placebo controlled phase I study in healthy individuals.
Klein R; Classen K; Berg PA; Lüdtke R; Werner M; Huber R
Eur J Med Res; 2002 Apr; 7(4):155-63. PubMed ID: 12010650
[TBL] [Abstract][Full Text] [Related]
15. Structure and properties of polysaccharides from Viscum album (L.).
Jordan E; Wagner H
Oncology; 1986; 43 Suppl 1():8-15. PubMed ID: 3808577
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic effects of the components in heat-treated mistletoe (Viscum album).
Park JH; Hyun CK; Shin HK
Cancer Lett; 1999 May; 139(2):207-13. PubMed ID: 10395180
[TBL] [Abstract][Full Text] [Related]
17. Anti-mistletoe lectin antibodies are produced in patients during therapy with an aqueous mistletoe extract derived from Viscum album L. and neutralize lectin-induced cytotoxicity in vitro.
Stettin A; Schultze JL; Stechemesser E; Berg PA
Klin Wochenschr; 1990 Sep; 68(18):896-900. PubMed ID: 2124308
[TBL] [Abstract][Full Text] [Related]
18. Isolation and partial characterization of a small chitin-binding lectin from mistletoe (Viscum album).
Peumans WJ; Verhaert P; Pfüller U; Van Damme EJ
FEBS Lett; 1996 Nov; 396(2-3):261-5. PubMed ID: 8914999
[TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of immunoactive mistletoe lectin-I.
Beuth J
Anticancer Drugs; 1997 Apr; 8 Suppl 1():S53-5. PubMed ID: 9179369
[TBL] [Abstract][Full Text] [Related]
20. Modulation of cytotoxicity and enhancement of cytokine release induced by Viscum album L. extracts or mistletoe lectins.
Ribéreau-Gayon G; Jung ML; Frantz M; Anton R
Anticancer Drugs; 1997 Apr; 8 Suppl 1():S3-8. PubMed ID: 9179359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]